Archives des Organizational and behavioral innovation - OncoSTART https://oncostart.fr/places/category/organizational-and-behavioral-innovation/ Entreprendre contre le cancer Mon, 23 Sep 2024 13:51:21 +0000 fr-FR hourly 1 Cline research https://oncostart.fr/places/cline-research/?utm_source=rss&utm_medium=rss&utm_campaign=cline-research Mon, 23 Sep 2024 13:51:21 +0000 https://oncostart.fr/?post_type=gd_place&p=2728 Cline est une plateforme innovante dédiée à la mise en relation des acteurs des essais cliniques : médecins, promoteurs, investigateurs et patients. Elle garantit des échanges et un adressage sécurisé des patients éligibles. La plateforme permet la personnalisation des pages d’études avec visuels et vidéos,...

L’article Cline research est apparu en premier sur OncoSTART.

]]> Cline est une plateforme innovante dédiée à la mise en relation des acteurs des essais cliniques : médecins, promoteurs, investigateurs et patients. Elle garantit des échanges et un adressage sécurisé des patients éligibles. La plateforme permet la personnalisation des pages d’études avec visuels et vidéos, et propose en temps réel un pré-screening et un screening en ligne à la fois pour les patients et les médecins. Elle dispose également d’algorithmes avancés de matchmaking.

Contact : Alexis Bourla, CEO abourla@cline-research.com

Website : https://www.cline-research.com/

L’article Cline research est apparu en premier sur OncoSTART.

]]> Cureety https://oncostart.fr/places/cureety/?utm_source=rss&utm_medium=rss&utm_campaign=cureety Sat, 17 Apr 2021 12:06:06 +0000 https://oncostart.fr/?post_type=gd_place&p=395 Presentation Cureety, has developed and launched a digital telemonitoring platform for the follow-up of patients with cancer and with chronic diseases, with three main goals: 1. Accompany the patients on their care pathway and improve their lives. 2. Assist caregivers and optimize their work. 3....

L’article Cureety est apparu en premier sur OncoSTART.

]]> Presentation

Cureety, has developed and launched a digital telemonitoring platform for the follow-up of
patients with cancer and with chronic diseases, with three main goals:

1. Accompany the patients on their care pathway and improve their lives.
2. Assist caregivers and optimize their work.
3. Bring clinicians and pharma an innovative solution for collecting
high-quality real-world data on the diseases and their treatments.

 

Contact

francois@cureety.com

 

Address

33 rue de l’amirauté, 22100 Dinan

 

Website

https://www.cureety.com

 

Targeted indications : breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, supportive care, liver cancer, brain cancer, head & neck cancer, gastrointestinal cancer, gynecological cancer, bone cancer, genitourinary cancer, skin cancer, hematologic cancer, lymphoma, myeloma, leukemia, predictive toxicology.

L’article Cureety est apparu en premier sur OncoSTART.

]]> Deeplink Medical https://oncostart.fr/places/deeplink-medical/?utm_source=rss&utm_medium=rss&utm_campaign=deeplink-medical Sat, 17 Apr 2021 12:27:16 +0000 https://oncostart.fr/?post_type=gd_place&p=405 Presentation Deeplink Medical is a company specializing in the development of (tele) medicine software for healthcare professionals. On the initiative of 5 radiologists, Deeplink Medical builds its solutions by combining in-depth medical thinking and solid technology, supported by in-house multidisciplinary teams. Present in more than...

L’article Deeplink Medical est apparu en premier sur OncoSTART.

]]> Presentation

Deeplink Medical is a company specializing in the development of (tele) medicine software for healthcare professionals.
On the initiative of 5 radiologists, Deeplink Medical builds its solutions by combining in-depth medical thinking and solid technology, supported by in-house multidisciplinary teams.
Present in more than 100 healthcare establishments, Deeplink Medical is part of two major therapeutic areas, radiology and oncology.

 

Contact

communication@deeplink-medical.com

 

Address

22 rue seguin, 69003 Lyon

 

Website

deeplink-medical.com

 

Targeted indications : Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Stomach cancer, Liver cancer, Brain cancer, Head and neck cancers, Gastrointestinal cancers, Gynecological cancers, Bone cancer, Genitourinary cancers, Skin cancer

L’article Deeplink Medical est apparu en premier sur OncoSTART.

]]> MAELA https://oncostart.fr/places/maela/?utm_source=rss&utm_medium=rss&utm_campaign=maela Wed, 07 Jul 2021 16:54:02 +0000 https://oncostart.fr/?post_type=gd_place&p=1097 Presentation Maela digitizes the peri-hospital care pathways and optimizes patient care. Maela is the operational translation of 4P medicine: a personalized tool offering tailor-made medico-surgical courses, a Participatory patient approach, Preventive management of complications or side effects and the ultimate objective of having AI solutions....

L’article MAELA est apparu en premier sur OncoSTART.

]]> Presentation

Maela digitizes the peri-hospital care pathways and optimizes patient care. Maela is the operational translation of 4P medicine: a personalized tool offering tailor-made medico-surgical courses, a Participatory patient approach, Preventive management of complications or side effects and the ultimate objective of having AI solutions. in data management thus promoting the right treatment for the right patient.

 



Contact


aurelia.artru@maela.fr


 


Address


2 rue Claude Chappe 69370 Saint Didier Au Mont D’Or


 


Website


www.maela.fr 


 


Targeting indications :  All


L’article MAELA est apparu en premier sur OncoSTART.

]]>
					
		
		
			
		
		MyPL
		https://oncostart.fr/places/mypl/?utm_source=rss&utm_medium=rss&utm_campaign=mypl
		
		
		Fri, 02 Apr 2021 13:46:03 +0000
				https://oncostart.fr/?post_type=gd_place&p=273

					Presentation MyPL offers an innovative and holistic visualization platform for patient data, with the ambition of helping oncology experts in the conduct of their multidisciplinary consultation meetings (RCP). MyPL automates the centralization of data and the presentation of patient profiles in the form of an...


L’article MyPL est apparu en premier sur OncoSTART.

]]>
										Presentation


MyPL offers an innovative and holistic visualization platform for patient data, with the ambition of helping oncology experts in the conduct of their multidisciplinary consultation meetings (RCP). MyPL automates the centralization of data and the presentation of patient profiles in the form of an intelligent dashboard, facilitating exchanges and the decision-making process between healthcare professionals.


 


Contact


christophe.vergne@mypl.io


 


Address


12 avenue des Prés, 78180 Montigny-Le-Bretonneux


 


Website


www.mypl.io


 


Targeted indications : breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, supportive care, liver cancer, brain cancer, head & neck cancer, gastrointestinal cancer, gynecological cancer, bone cancer, genitourinary cancer, skin cancer, hematologic cancer, lymphoma, myeloma, leukemia, predictive toxicology.


L’article MyPL est apparu en premier sur OncoSTART.

]]>
					
		
		
			
		
		PROSTPERIA
		https://oncostart.fr/places/prostperia/?utm_source=rss&utm_medium=rss&utm_campaign=prostperia
		
		
		Fri, 17 Mar 2023 13:57:04 +0000
				https://oncostart.fr/?post_type=gd_place&p=1995

					PROSTPERIA’s mission is to support healthcare professionals and patients towards safer cancer screening. The company is developing a new generation of personalized “in silico” tests for large-scale cancer screening and aims to improve the sharing of information throughout the patient journey. Contact nicolas.martelin@prostperia.com   Address...


L’article PROSTPERIA est apparu en premier sur OncoSTART.

]]>
										PROSTPERIA’s mission is to support healthcare professionals and patients towards safer cancer screening. The company is developing a new generation of personalized “in silico” tests for large-scale cancer screening and aims to improve the sharing of information throughout the patient journey.


Contact


nicolas.martelin@prostperia.com


 


Address


Nancy


 


Contact


www.prostperia.com


 


Targeted indications : Prostate cancer, Gynecological cancer


L’article PROSTPERIA est apparu en premier sur OncoSTART.

]]>
					
		
		
			
		
		Tumoscan
		https://oncostart.fr/places/tumoscan/?utm_source=rss&utm_medium=rss&utm_campaign=tumoscan
		
		
		Tue, 09 Jul 2024 10:24:32 +0000
				https://oncostart.fr/?post_type=gd_place&p=2672

					Tumoscan analyse rapidement et précisément tous les types d’imageries, intégrant le score BI-RADS pour une détection précoce et évitant les biopsies inutiles. Notre IA offre des rapports instantanés et prend en compte la densité mammaire, tout en s’intégrant parfaitement aux pratiques existantes CONTACT: CEO :...


L’article Tumoscan est apparu en premier sur OncoSTART.

]]>
										Tumoscan analyse rapidement et précisément tous les types d’imageries, intégrant le score BI-RADS pour une détection précoce et évitant les biopsies inutiles. Notre IA offre des rapports instantanés et prend en compte la densité mammaire, tout en s’intégrant parfaitement aux pratiques existantes


CONTACT:


CEO : Yassine Maghnouj, Yassine@dexalgo.fr


WEBSITE www.tumoscan.com


L’article Tumoscan est apparu en premier sur OncoSTART.

]]>
					
		
		
			
		
		vencot
		https://oncostart.fr/places/vencot/?utm_source=rss&utm_medium=rss&utm_campaign=vencot
		
		
		Mon, 23 Sep 2024 07:55:45 +0000
				https://oncostart.fr/?post_type=gd_place&p=2725

					We help medtech companies get their regulatory approval and ensure continuous compliance by making the process fast and accessible for everyone. With vencot, we are transforming weeks of work into minutes. Contact : Yousra El Merini, CEO yelmerini@vencot.com Website : www.vencot.com  


L’article vencot est apparu en premier sur OncoSTART.

]]>
										We help medtech companies get their regulatory approval and ensure continuous compliance by making the process fast and accessible for everyone. With vencot, we are transforming weeks of work into minutes.


Contact : Yousra El Merini, CEO yelmerini@vencot.com


Website : www.vencot.com


 


L’article vencot est apparu en premier sur OncoSTART.

]]>